Global Coronary Stents Market, 2020-2026
The global coronary stents market size was valued at $5,311.22 million in 2019 and is projected to reach $8,351.7 million by 2026, registering a CAGR of 6.68% from 2020 to 2026. The report offers a breakdown of market shares by product, including Drug-eluting Stents (DESs), Bare Metal Stents (BMSs), Bioresorbable Stents (BRSs). Based on design, the market for coronary stents is segmented into Permanent Coronary Stents, Fully Degradable Coronary Stents. By application, the coronary stents market is classified into Hospitals, Ambulatory Surgical Centers (ASCs). On the basis of region, the coronary stents industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).
By Product:
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
By Product:
- Drug-eluting Stents (DESs)
- Bare Metal Stents (BMSs)
- Bioresorbable Stents (BRSs)
- Permanent Coronary Stents
- Fully Degradable Coronary Stents
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- North America (U.S., Canada, Mexico, etc.)
- Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
- Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
- Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
- South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biosensors International Ltd.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Lepu Medical Technology (Beijing) Co., Ltd.
- Medtronic plc
- MicroPort Scientific Corporation
- Sahajanand Medical Technologies Pvt. Ltd.
- Terumo Corporation
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
- To analyze and forecast the market size of global coronary stents market.
- To classify and forecast global coronary stents market based on product, design, application.
- To identify drivers and challenges for global coronary stents market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global coronary stents market.
- To conduct pricing analysis for global coronary stents market.
- To identify and analyze the profile of leading players operating in global coronary stents market.
- Manufacturers of coronary stents
- Raw material suppliers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to coronary stents
PART 1. INTRODUCTION
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition
PART 5. GLOBAL MARKET FOR CORONARY STENTS BY PRODUCT
5.1 Market Overview
5.2 Drug-eluting Stents (DESs)
5.2.1 Market Size and Forecast
5.3 Bare Metal Stents (BMSs)
5.3.1 Market Size and Forecast
5.4 Bioresorbable Stents (BRSs)
5.4.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR CORONARY STENTS BY DESIGN
6.1 Market Overview
6.2 Permanent Coronary Stents
6.2.1 Market Size and Forecast
6.3 Fully Degradable Coronary Stents
6.3.1 Market Size and Forecast
PART 7. GLOBAL MARKET FOR CORONARY STENTS BY APPLICATION
7.1 Market Overview
7.2 Hospitals
7.2.1 Market Size and Forecast
7.3 Ambulatory Surgical Centers (ASCs)
7.3.1 Market Size and Forecast
PART 8. GLOBAL MARKET FOR CORONARY STENTS BY GEOGRAPHY
8.1 Overview
8.1.1 Market Size and Forecast
8.2 North America
8.2.1 Market Size and Forecast
8.2.2 North America: Coronary Stents Market by Country
8.2.2.1 United States
8.2.2.2 Canada
8.2.2.3 Mexico
8.3 Europe
8.3.1 Market Size and Forecast
8.3.2 Europe: Coronary Stents Market by Country
8.3.2.1 Germany
8.3.2.2 France
8.3.2.3 United Kingdom
8.3.2.4 Italy
8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
8.4.1 Market Size and Forecast
8.4.2 Asia-Pacific: Coronary Stents Market by Country
8.4.2.1 China
8.4.2.2 India
8.4.2.3 Japan
8.4.2.4 South Korea
8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
8.5.1 Market Size and Forecast
8.5.2 MEA: Coronary Stents Market by Country
8.5.2.1 Saudi Arabia
8.5.2.2 South Africa
8.5.2.3 Turkey
8.6 South America
8.6.1 Market Size and Forecast
8.6.2 South America: Coronary Stents Market by Country
8.6.2.1 Brazil
8.6.2.2 Argentina
8.6.2.3 Rest of South America
PART 9. COMPETITIVE LANDSCAPE
9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships
PART 10. KEY COMPETITOR PROFILES
10.1 Abbott Laboratories
10.2 B. Braun Melsungen AG
10.3 Becton, Dickinson and Company
10.4 Biosensors International Ltd.
10.5 BIOTRONIK SE & Co. KG
10.6 Boston Scientific Corporation
10.7 Lepu Medical Technology (Beijing) Co., Ltd.
10.8 Medtronic plc
10.9 MicroPort Scientific Corporation
10.10 Sahajanand Medical Technologies Pvt. Ltd.
10.11 Terumo Corporation
*LIST IS NOT EXHAUSTIVE
PART 11. PATENT ANALYSIS
11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis
DISCLAIMER
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition
PART 5. GLOBAL MARKET FOR CORONARY STENTS BY PRODUCT
5.1 Market Overview
5.2 Drug-eluting Stents (DESs)
5.2.1 Market Size and Forecast
5.3 Bare Metal Stents (BMSs)
5.3.1 Market Size and Forecast
5.4 Bioresorbable Stents (BRSs)
5.4.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR CORONARY STENTS BY DESIGN
6.1 Market Overview
6.2 Permanent Coronary Stents
6.2.1 Market Size and Forecast
6.3 Fully Degradable Coronary Stents
6.3.1 Market Size and Forecast
PART 7. GLOBAL MARKET FOR CORONARY STENTS BY APPLICATION
7.1 Market Overview
7.2 Hospitals
7.2.1 Market Size and Forecast
7.3 Ambulatory Surgical Centers (ASCs)
7.3.1 Market Size and Forecast
PART 8. GLOBAL MARKET FOR CORONARY STENTS BY GEOGRAPHY
8.1 Overview
8.1.1 Market Size and Forecast
8.2 North America
8.2.1 Market Size and Forecast
8.2.2 North America: Coronary Stents Market by Country
8.2.2.1 United States
8.2.2.2 Canada
8.2.2.3 Mexico
8.3 Europe
8.3.1 Market Size and Forecast
8.3.2 Europe: Coronary Stents Market by Country
8.3.2.1 Germany
8.3.2.2 France
8.3.2.3 United Kingdom
8.3.2.4 Italy
8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
8.4.1 Market Size and Forecast
8.4.2 Asia-Pacific: Coronary Stents Market by Country
8.4.2.1 China
8.4.2.2 India
8.4.2.3 Japan
8.4.2.4 South Korea
8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
8.5.1 Market Size and Forecast
8.5.2 MEA: Coronary Stents Market by Country
8.5.2.1 Saudi Arabia
8.5.2.2 South Africa
8.5.2.3 Turkey
8.6 South America
8.6.1 Market Size and Forecast
8.6.2 South America: Coronary Stents Market by Country
8.6.2.1 Brazil
8.6.2.2 Argentina
8.6.2.3 Rest of South America
PART 9. COMPETITIVE LANDSCAPE
9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships
PART 10. KEY COMPETITOR PROFILES
10.1 Abbott Laboratories
10.2 B. Braun Melsungen AG
10.3 Becton, Dickinson and Company
10.4 Biosensors International Ltd.
10.5 BIOTRONIK SE & Co. KG
10.6 Boston Scientific Corporation
10.7 Lepu Medical Technology (Beijing) Co., Ltd.
10.8 Medtronic plc
10.9 MicroPort Scientific Corporation
10.10 Sahajanand Medical Technologies Pvt. Ltd.
10.11 Terumo Corporation
*LIST IS NOT EXHAUSTIVE
PART 11. PATENT ANALYSIS
11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY